In conclusion, we observed the reduced FTO and ALKBH5 expression levels in CRC tissues and cell lines, whereby FTO and ALKBH5 were robustly down-regulated in obese CRC patients and CRC cells treated with sodium palmitate. The gene discussed is FTO; the disease is colorectal carcinoma.